RANKINGS

POPULAR STOCKS

Cytori Cell Research Institute, Inc.

Tokyo Stock Exchange:3750.T

Location

Japan

Market Cap

USD 48.48 M

Share Price

USD 5.43

Avg Daily Volume

29,596

Change (1 day)

3.86%

Change (1 year)

Change (YTD)

-1.47%

Cytori Cell Research Institute, Inc. Operating Income for the year ending March 31, 2025: USD -5.38 M

Cytori Cell Research Institute, Inc. Operating Income is USD -5.38 M for the year ending March 31, 2025, a 5.35% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Cytori Cell Research Institute, Inc. Operating Income for the year ending March 31, 2024 was USD -5.11 M, a -14.61% change year over year.
  • Cytori Cell Research Institute, Inc. Operating Income for the year ending March 31, 2023 was USD -5.98 M, a 57.43% change year over year.
  • Cytori Cell Research Institute, Inc. Operating Income for the year ending March 31, 2022 was USD -3.80 M, a -42.52% change year over year.
  • Cytori Cell Research Institute, Inc. Operating Income for the year ending March 31, 2021 was USD -6.61 M, a 450.78% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Tokyo Stock Exchange: 3750.T

Cytori Cell Research Institute, Inc.

CEO Mr. Yoshihiro Hoshino
IPO Date Jan. 1, 2001
Location Japan
Headquarters Otemachi Park Building, 1-1-1 Otemachi
Employees 16
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
🏥 Hospitals & Clinics
🩺 Medical Instruments
Description

Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, including anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn's disease fistulas, erectile dysfunction, etc. It also invests in, owns, develops, leases, and manages real estate projects and hotels; and provides real estate brokerage services. The company was formerly known as FRACTALE Corporation. Cytori Cell Research Institute, Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan.

Similar companies

MRK

Merck & Co., Inc.

USD 79.10

0.34%

SHL.DE

Siemens Healthineers AG

USD 54.95

0.27%

207940.KS

Samsung Biologics Co.,Ltd.

USD 727.08

-0.57%

BIM.PA

bioMérieux S.A.

USD 139.42

-0.45%

BAX

Baxter International Inc.

USD 30.39

-0.36%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.07

0.74%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.08%

GMED

Globus Medical, Inc.

USD 58.60

-0.37%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.91

0.12%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.80

-2.41%

688617.SS

APT Medical Inc.

USD 41.29

1.54%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.29%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.67

-0.69%

TMDX

TransMedics Group, Inc.

USD 131.45

1.07%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.01%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.96

0.64%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 13.73

-0.26%

0853.HK

MicroPort Scientific Corporation

USD 1.10

-0.01%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.49

0.40%

QDEL

QuidelOrtho Corporation

USD 28.87

0.59%

NVCR

NovoCure Limited

USD 18.00

5.26%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.02

2.05%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.65

-0.57%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.51

0.20%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.19

-0.25%

ABBV

AbbVie Inc.

USD 182.31

-2.40%

NOVO-B.CO

Novo Nordisk A/S

USD 68.56

1.71%

RO.SW

Roche Holding AG

USD 347.50

0.20%

ABT

Abbott Laboratories

USD 134.38

0.53%

NOVN.SW

Novartis AG

USD 120.31

0.29%

AZN.L

AstraZeneca PLC

USD 140.24

0.73%

TMO

Thermo Fisher Scientific Inc.

USD 408.28

-0.93%

BSX

Boston Scientific Corporation

USD 106.53

1.86%

AMGN

Amgen Inc.

USD 277.13

-0.71%

PFE

Pfizer Inc.

USD 24.19

-0.21%

GILD

Gilead Sciences, Inc.

USD 110.67

2.83%

SAN.PA

Sanofi

USD 96.65

0.37%

VRTX

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

BMY

Bristol-Myers Squibb Company

USD 46.35

-0.64%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK.L

GSK plc

USD 19.28

0.69%

CSL.AX

CSL Limited

USD 153.01

-2.58%

COR

Cencora, Inc.

USD 299.42

0.96%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

BDX

Becton, Dickinson and Company

USD 170.86

0.52%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

StockViz Staff

June 28, 2025

Any question? Send us an email